SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced today that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent...
Hence then, the article about abbisko therapeutics announces fda acceptance of the nda for pimicotinib for the treatment of tenosynovial giant cell tumor was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor )
Also on site :
- Fans Rally Behind ‘Vampire Diaries’ Star Steven R. McQueen, 38, After Years Away
- In 1945, a Missouri asphalt company began mining limestone in Clay County; the mine is now SubTropolis, an underground business park with more than 2,000 workers and over 10 miles of road
- ‘Happy Days’ Star Released a Bubblegum Pop Album in 1976 – But It Wasn’t the Record He Wanted to Make